it contains important information for the patient.
If there are any contraindications to vaccination with d - Diphtheria vaccine adsorbed, the doctor should assess the risk of administering the vaccine in relation to the risk of infection.
Before starting to use d - Diphtheria vaccine adsorbed, you should discuss it with your doctor or nurse if any side effects described in section 4 occurred after the previous dose of the vaccine or any other worrying reactions. Vaccination should be preceded by a medical examination and interview on the overall health condition and previously performed and recorded vaccinations. This procedure allows for predicting the risk of side effects after vaccination.
The vaccine contains thiomersal as a preservative, so allergic reactions may occur in the vaccinated person. You should inform your doctor if you have had or have known allergic reactions. You should also inform your doctor if you have had any health disorders after previous vaccination.
You should tell your doctor about all medicines that the patient is currently taking or has recently taken, as well as medicines that the patient plans to take.
The vaccine can only be administered in the event of a serious risk of diphtheria infection. In such a case, the decision is made by the doctor. Breastfeeding is not a contraindication to vaccination. If the patient is pregnant or breastfeeding, suspects that she may be pregnant, or plans to have a child, she should consult her doctor before using this vaccine.
The vaccine has no influence or has a negligible influence on the ability to drive and operate machinery.
The vaccine will be administered by a doctor or nurse as a deep subcutaneous injection. The recommended injection site is the deltoid muscle. The vaccine should never be administered intravascularly. Booster vaccination
Overdose is unlikely, as the packaging is single-dose. In case of doubt, you should consult a doctor.
In case of any further doubts related to the use of the vaccine, you should consult a doctor, pharmacist, or nurse.
Like any vaccine, this vaccine can cause side effects, although not everybody gets them.
If you experience any side effects, including any side effects not listed in this leaflet, you should inform your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of the vaccine.
Store upright, in a refrigerator (2°C - 8°C). Do not freeze, in case of freezing, the vaccine should be destroyed. The vaccine should be stored out of sight and reach of children. Do not use the vaccine after the expiry date stated on the carton. The expiry date refers to the last day of the given month. Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of the vaccine is: Diphtheria toxoid not less than 5 IU adsorbed on hydrated aluminum hydroxide not more than 0.5 mg Al The other ingredients of the vaccine are: thiomersal, sodium chloride, and water for injections.
The vaccine is a white or almost white, homogeneous suspension in glass ampoules. During storage, a white sediment forms at the bottom of the ampoule, and a clear supernatant (liquid) forms above it. The packaging contains 5 or 15 ampoules. Not all pack sizes may be marketed.
Biomed S.A. Al. Sosnowa 8 30-224 Krakow Tel.: +48 12 37 69 200 Fax: +48 12 37 69 205 e-mail: informacjanaukowa@biomed.pl
Before use, shake to obtain a homogeneous suspension. You should visually inspect the vaccine for any foreign particles and/or changes in its appearance. If any changes are observed, the vaccine should not be used. The dose of 0.5 ml should be administered deep subcutaneously. The recommended injection site is the deltoid muscle. Do not administer intravascularly! Make sure the needle is not inserted into a blood vessel. Note: due to the risk of anaphylactic shock associated with vaccination, the vaccination room should be equipped with a standard anaphylaxis kit.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.